Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

716 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Extracellular cardiac matrix biomarkers in patients with acute myocardial infarction complicated by left ventricular dysfunction and heart failure: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study (EPHESUS) study.
Iraqi W, Rossignol P, Angioi M, Fay R, Nuée J, Ketelslegers JM, Vincent J, Pitt B, Zannad F. Iraqi W, et al. Among authors: rossignol p. Circulation. 2009 May 12;119(18):2471-9. doi: 10.1161/CIRCULATIONAHA.108.809194. Epub 2009 Apr 27. Circulation. 2009. PMID: 19398668 Clinical Trial.
Extracellular matrix fibrotic markers in heart failure.
Zannad F, Rossignol P, Iraqi W. Zannad F, et al. Among authors: rossignol p. Heart Fail Rev. 2010 Jul;15(4):319-29. doi: 10.1007/s10741-009-9143-0. Heart Fail Rev. 2010. PMID: 19404737 Review.
Vascular effects of cardiotrophin-1: a role in hypertension?
Lopez-Andres N, Fortuno MA, Diez J, Zannad F, Lacolley P, Rossignol P. Lopez-Andres N, et al. Among authors: rossignol p. J Hypertens. 2010 Jun;28(6):1261-72. doi: 10.1097/HJH.0b013e328337fe42. J Hypertens. 2010. PMID: 20216087
Eplerenone survival benefits in heart failure patients post-myocardial infarction are independent from its diuretic and potassium-sparing effects. Insights from an EPHESUS (Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study) substudy.
Rossignol P, Ménard J, Fay R, Gustafsson F, Pitt B, Zannad F. Rossignol P, et al. J Am Coll Cardiol. 2011 Nov 1;58(19):1958-66. doi: 10.1016/j.jacc.2011.04.049. J Am Coll Cardiol. 2011. PMID: 22032706 Free article.
Determinants and consequences of renal function variations with aldosterone blocker therapy in heart failure patients after myocardial infarction: insights from the Eplerenone Post-Acute Myocardial Infarction Heart Failure Efficacy and Survival Study.
Rossignol P, Cleland JG, Bhandari S, Tala S, Gustafsson F, Fay R, Lamiral Z, Dobre D, Pitt B, Zannad F. Rossignol P, et al. Circulation. 2012 Jan 17;125(2):271-9. doi: 10.1161/CIRCULATIONAHA.111.028282. Epub 2011 Nov 29. Circulation. 2012. PMID: 22128223 Clinical Trial.
716 results